Needham analyst Mike Matson downgraded Hologic (NASDAQ: HOLX) from Buy to Hold.The analyst comments "We are downgrading HOLX shares from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE